MARKET

CNCR

CNCR

Loncar Cancer Immunotherapy ETF
NASDAQ
17.33
+0.69
+4.17%
Opening 11:27 02/27 EST
OPEN
17.09
PREV CLOSE
16.64
HIGH
17.41
LOW
16.96
VOLUME
33.37K
TURNOVER
0
52 WEEK HIGH
17.41
52 WEEK LOW
9.22
TOTAL ASSET
18.76M
YTD YIELD
25.26%
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CNCR last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at CNCR last week (0212-0216)?
Weekly Report · 02/19 10:57
5 Sector ETFs Beating the Market Halfway Through Q1
NASDAQ · 02/12 16:05
Weekly Report: what happened at CNCR last week (0205-0209)?
Weekly Report · 02/12 10:48
Dealmaking Outlook: Unsettled, With Bright Spots
Seeking Alpha · 02/07 06:53
Weekly Report: what happened at CNCR last week (0129-0202)?
Weekly Report · 02/05 10:55
Barbell Equity Exposure In '24
Seeking Alpha · 01/31 09:36
Weekly Report: what happened at CNCR last week (0122-0126)?
Weekly Report · 01/29 10:47
More
Profile
Fund Name
Loncar Cancer Immunotherapy ETF
Inception Date
2015-10-13
Benchmark
Loncar Cancer Immunotherapy TR USD
Advisor Company
Exchange Traded Concepts LLC
Custodian
US Bank NA
Manager
Rafael Zayas, Austin Wen, Andrew Serowik, Gabriel Tan, Todd Alberico, Brian Cooper